ASX Filings

Ceasing to be a substantial holder

March 18, 2020

Change in substantial holding

March 18, 2020

Becoming a substantial holder

March 13, 2020

Opthea Half Year Report and Accounts

February 26, 2020

Opthea to Present at the 9th Annual SVB Leerink Global Healthcare Conference

February 18, 2020

Additional Formats

PDF Version

Ceasing to be a substantial holder

January 16, 2020

Becoming a substantial holder

January 9, 2020

Opthea Completes Recruitment in Phase 2a Clinical Trial of OPT-302 for Diabetic Macular Edema

January 7, 2020

Additional Formats

PDF Version

Ceasing to be a substantial holder

December 16, 2019

Becoming a substantial holder

December 12, 2019